Skip to main content

Table 5 Immunophenotypical characterization of equine mesenchymal stromal cells derived from umbilical cord blood, peripheral blood, and umbilical cord matrix, expressed as the percentage of cells positive for each marker

From: Characterization and profiling of immunomodulatory genes of equine mesenchymal stromal cells from non-invasive sources

Marker

UCB

PB

UCM

CD29pos

99.6 ± 0.2a

98.2 ± 0.9a

98.4 ± 1.0a

CD44pos

99.2 ± 0.2b

96.6 ± 4.1

97.3 ± 1.1

CD73pos

0.5 ± 0.5c,d

0.8 ± 0.5

0.5 ± 0.1

CD90pos

99.4 ± 0.3

97.8 ± 2.4

66.9 ± 27.6a

CD105pos

2.7 ± 3.4

1.2 ± 1.6

46.2 ± 64.3

MHC-Ipos

80.3 ± 12.9

62.7 ± 24.8c

77.6 ± 11.8

CD45neg

0.5 ± 0.3

1.8 ± 0.9

1.1 ± 1.4

CD79αneg

0.1 ± 0.1c

1.0 ± 1.0c

0.1 ± 0*

Monocyte markerneg

0.2 ± 0.1b,d

1.3 ± 1.2

1.0 ± 1.3

MHC-IIneg

0.5 ± 0.5

0.8 ± 0.7

0.8 ± 0.6

  1. Indicated source is significantly different from both other sources at least at aP<0.001, bP<0.01, cP<0.05. dOnly significantly different from peripheral blood (PB). Data are presented as average ± standard deviation (n = 6, except for umbilical cord matrix (UCM), n = 2). UCB, umbilical cord blood.